Inhibition of fatty acid synthase or palmitoyltransferase diminishes EGFR activity, leading to a reduction in EGFR levels, rendering cancer cells more responsive to EGFR tyrosine kinase inhibitors 42. This evidence concerns the gene EGFR and cancer.